Found: 9
Select item for more details and to access through your institution.
Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer.
- Published in:
- Disease Markers, 2022, p. 1, doi. 10.1155/2022/8724035
- By:
- Publication type:
- Article
Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
- Published in:
- International Urology & Nephrology, 2017, v. 49, n. 5, p. 817, doi. 10.1007/s11255-017-1545-7
- By:
- Publication type:
- Article
Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA‐30d in patient with prostate cancer.
- Published in:
- Journal of Cellular Biochemistry, 2018, v. 119, n. 9, p. 7245, doi. 10.1002/jcb.26913
- By:
- Publication type:
- Article
Novel immune‐related signature for risk stratification and prognosis in prostatic adenocarcinoma.
- Published in:
- Cancer Science, 2021, v. 112, n. 10, p. 4365, doi. 10.1111/cas.15062
- By:
- Publication type:
- Article
miR-505 suppresses prostate cancer progression by targeting NRCAM.
- Published in:
- Oncology Reports, 2020, v. 44, n. 4, p. 1771
- By:
- Publication type:
- Article
miR-505 suppresses prostate cancer progression by targeting NRCAM.
- Published in:
- Oncology Reports, 2019, v. 42, n. 3, p. 991, doi. 10.3892/or.2019.7231
- By:
- Publication type:
- Article